Halozyme Therapeutics, Inc. SEC filings HALO
Halozyme Therapeutics, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Dec 12, 2011. Its latest annual report, Form ARS, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Nov 18, 2025 | — |
| S-8 | Employee stock plan registration | May 5, 2021 | — |
| S-8 | Employee stock plan registration | May 5, 2021 | — |
| S-8 POS | 2005 and 2006 plan deregistration | May 14, 2019 | — |
| S-8 POS | 2004 plan deregistration | May 14, 2019 | — |
| S-8 | Employee stock plan registration | May 10, 2018 | — |
| 424B5 | Prospectus supplement | May 19, 2017 | — |
| 424B5 | Prospectus supplement | May 18, 2017 | — |
| S-3ASR | Automatic shelf registration | Feb 28, 2017 | — |
| S-8 | Employee stock plan registration | May 9, 2016 | — |
| S-8 | Employee stock plan registration | Aug 10, 2015 | — |
| 424B5 | Prospectus supplement | Feb 5, 2014 | — |
| 424B5 | Prospectus supplement | Feb 3, 2014 | — |
| S-8 | Employee stock plan registration | May 31, 2013 | — |
| 424B5 | Prospectus supplement | Feb 10, 2012 | — |
| 424B5 | Prospectus supplement | Feb 9, 2012 | — |
| S-3ASR | Automatic shelf registration | Feb 9, 2012 | — |
Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- HALO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1159036
- Former names
- HALOZYME THERAPEUTICS INC (until Jul 3, 2019); GLOBAL YACHT SERVICES INC (until Mar 12, 2004)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.